Position history for VIKING GLOBAL INVESTORS LP's holdings in 4D MOLECULAR THERAPEUTICS IN
VIKING GLOBAL INVESTORS LP previously held 0 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $0 as of 2024-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$61.6M
Total Shares Change
-2.9M
Other major holders of FDMT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $10.83 |
0 |
| 2024-Q2 | Unchanged | 2.9M | 0.0% | $61.6M | 0.2% | $20.99 | 0 |